219 related articles for article (PubMed ID: 23656271)
21. Radical surgical management of periampullary duodenal adenocarcinoma: a single institution experience.
Bhatti AB; Yosuf MA; Syed AA
J Pak Med Assoc; 2014 Nov; 64(11):1260-4. PubMed ID: 25831642
[TBL] [Abstract][Full Text] [Related]
22. The histopathologic type of the periampullary tumors. Is it important for survival?
Georgescu SO; Neacşu CN; Vintilă D; Popa P; Florea N; Mihailovici MS
Chirurgia (Bucur); 2009; 104(6):697-700. PubMed ID: 20187467
[TBL] [Abstract][Full Text] [Related]
23. Duodenal adenocarcinoma: Surgical results of 27 patients treated at a single center.
López-Domínguez J; Busquets J; Secanella L; Peláez N; Serrano T; Fabregat J
Cir Esp (Engl Ed); 2019 Nov; 97(9):523-530. PubMed ID: 31563268
[TBL] [Abstract][Full Text] [Related]
24. Primary adenocarcinoma of the duodenum: treatment and survival in 89 patients.
Santoro E; Sacchi M; Scutari F; Carboni F; Graziano F
Hepatogastroenterology; 1997; 44(16):1157-63. PubMed ID: 9261617
[TBL] [Abstract][Full Text] [Related]
25. Survival predictors of patients with primary duodenal adenocarcinoma.
Kawahira H; Miura F; Saigo K; Matsunaga A; Natsume T; Akai T; Horibe D; Suzuki K; Nabeya Y; Hayashi H; Miyauchi H; Shuto K; Asano T; Matsubara H
Int Surg; 2011; 96(2):111-6. PubMed ID: 22026300
[TBL] [Abstract][Full Text] [Related]
26. Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience.
Hung FC; Kuo CM; Chuah SK; Kuo CH; Chen YS; Lu SN; Chang Chien CS
J Gastroenterol Hepatol; 2007 May; 22(5):724-8. PubMed ID: 17444863
[TBL] [Abstract][Full Text] [Related]
27. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
28. Does the extent of resection impact survival for duodenal adenocarcinoma? Analysis of 1,611 cases.
Cloyd JM; Norton JA; Visser BC; Poultsides GA
Ann Surg Oncol; 2015 Feb; 22(2):573-80. PubMed ID: 25160736
[TBL] [Abstract][Full Text] [Related]
29. Should all patients with duodenal adenocarcinoma be considered for aggressive surgical resection?
Hurtuk MG; Devata S; Brown KM; Oshima K; Aranha GV; Pickleman J; Shoup M
Am J Surg; 2007 Mar; 193(3):319-24; discussion 324-5. PubMed ID: 17320527
[TBL] [Abstract][Full Text] [Related]
30. Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma.
Malleo G; Tonsi A; Marchegiani G; Casarotto A; Paiella S; Butturini G; Salvia R; Bassi C
Langenbecks Arch Surg; 2013 Feb; 398(2):287-94. PubMed ID: 22801737
[TBL] [Abstract][Full Text] [Related]
31. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
[TBL] [Abstract][Full Text] [Related]
32. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
[TBL] [Abstract][Full Text] [Related]
33. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
[TBL] [Abstract][Full Text] [Related]
34. [Surgical resection of tumors in the distal duodenum].
Wellner I; Banga P; Haulik L; Rácz I; Kecskés G
Magy Seb; 2001 Aug; 54(4):215-8. PubMed ID: 11550487
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant chemotherapy for small bowel adenocarcinoma after curative surgery.
Koo DH; Yun SC; Hong YS; Ryu MH; Lee JL; Chang HM; Kang YK; Kim SC; Han DJ; Lee YJ; Kim TW
Oncology; 2011; 80(3-4):208-13. PubMed ID: 21720183
[TBL] [Abstract][Full Text] [Related]
36. Primary duodenal adenocarcinoma: a 40-year experience.
Ryder NM; Ko CY; Hines OJ; Gloor B; Reber HA
Arch Surg; 2000 Sep; 135(9):1070-4; discussion 1074-5. PubMed ID: 10982512
[TBL] [Abstract][Full Text] [Related]
37. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
[TBL] [Abstract][Full Text] [Related]
38. Surgical outcomes for duodenal adenoma and adenocarcinoma: a multicentre study in Australia and the United Kingdom.
Lee CHA; Shingler G; Mowbray NG; Al-Sarireh B; Evans P; Smith M; Usatoff V; Pilgrim C
ANZ J Surg; 2018 Mar; 88(3):E157-E161. PubMed ID: 28122405
[TBL] [Abstract][Full Text] [Related]
39. Duodenal Adenocarcinoma: Profile and Predictors of Survival Outcomes.
Oyasiji T; Alosi J; Tan W; Wilfong C; Wilkinson N
Am Surg; 2015 Nov; 81(11):1125-33. PubMed ID: 26672582
[TBL] [Abstract][Full Text] [Related]
40. The surgical treatment and outcome for primary duodenal adenocarcinoma.
Han SL; Cheng J; Zhou HZ; Zeng QQ; Lan SH
J Gastrointest Cancer; 2009; 40(1-2):33-7. PubMed ID: 19513860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
